---
title: Jewel P-WCD Post-Approval Study (PAS)
nct_id: NCT07256678
overall_status: NOT_YET_RECRUITING
sponsor: Element Science, Inc.
study_type: OBSERVATIONAL
primary_condition: Jewel-P WCD
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT07256678.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT07256678"
ct_last_update_post_date: 2025-12-01
last_seen_at: "2026-05-12T07:33:41.885Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Jewel P-WCD Post-Approval Study (PAS)

**NCT ID:** [NCT07256678](https://clinicaltrials.gov/study/NCT07256678)

## Key Facts

- **Status:** NOT_YET_RECRUITING
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 6330
- **Lead Sponsor:** Element Science, Inc.
- **Conditions:** Jewel-P WCD
- **Start Date:** 2026-01
- **Completion Date:** 2029-12
- **CT.gov Last Update:** 2025-12-01

## Brief Summary

The objective of this PAS is to demonstrate the continued safety and clinical effectiveness of the Jewel P-WCD.

## Detailed Description

This study is an observational registry study of the Jewel P-WCD in post-market use

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* N/A - registry will collect data already obtained commercially from patients prescribed the Jewel P-WCD.

Exclusion Criteria:

* N/A - registry will collect data already obtained through commercial consent from patients prescribed the Jewel P-WCD
```

## Arms

- **This study is an observational registry study of the Jewel P-WCD in post-market use**

## Interventions

- **This study is an observational registry study of the Jewel P-WCD in post-market use** (OTHER) — This study is an observational registry study of the Jewel P-WCD in post-market use
- **Jewel** (OTHER) — This study is an observational registry study of the Jewel P-WCD in post-market use

## Primary Outcomes

- **Percent of VT/VF events successfully detected by the Jewel P-WCD** _(time frame: From enrollment to the end of treatment at approximately 90 days)_

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT07256678.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT07256678*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*